Stocktoria
VACCINEX, INC. VCNX
OTC · stock · Pharmaceutical Preparations · website · IPO 2018-08-09
VACCINEX, INC. statistics & valuation
Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Operating margin | -3117.3% | -4014.9% | -7238.5% | -2498.9% | -4533.0% | -6121.4% | -3768.1% | -23448.9% |
| Net margin | -3100.5% | -3552.8% | -7205.5% | -2486.7% | -4616.2% | -6092.4% | -4077.1% | -20802.2% |
| FCF margin | -2696.8% | -3762.5% | -6972.0% | -2814.4% | -4629.9% | -5887.8% | -3523.6% | -23838.9% |
| Return on assets | -717.8% | -557.7% | -248.4% | -227.4% | -246.5% | -692.1% | -134.0% | -335.8% |
| Return on equity | 749.0% | 876.3% | -381.6% | -301.9% | 108.6% | 121.4% | -192.4% | 14.9% |
| Debt / equity | -0.00× | -0.01× | 0.02× | 0.02× | -0.04× | — | — | — |
| Current ratio | 0.50 | 0.57 | 2.95 | 4.17 | 0.86 | 0.58 | 3.20 | 1.19 |
Computed from company filings · US · as of 2024-12-31. Facts plus Stocktoria's own computed scores — not investment advice.